Cycle Pharmaceuticals Revenue

Pharmaceutical Manufacturing • Cambridge, England, United Kingdom • 101-200 Employees

Cycle Pharmaceuticals revenue & valuation

Annual revenue	$32,000,000
Revenue per employee	$176,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$102,400,000
Total funding	$25,000,000

Key Contacts at Cycle Pharmaceuticals

Ken Susf

Director Of Patient Hub Technology

Chuck Bradley

Director Of Sales - Southeast U.S.

David Rich

Director Of Sales, Hematology & Oncology

Mark Brubaker

Director - Sales, Neurology West

Adriene Jarrell

Director Of Sales, East

Robert Searson

Associate Director Regulatory Affairs, Cmc & Labelling

Matthew A Lee

Business Development Director

Shweata Dhanuka

Associate Director Commercial Operations

Abby Stubbs

Director Rare Disease Sales, Mid - West

Jamie Ray

Director, Patient Support Program

Company overview

Headquarters	The Broers Building, 21 JJ Thomson Avenue, Cambridge, Cambridgeshire CB3 0FA, GB
Phone number	+448009031793
Website	cyclepharma.com
NAICS	3254
SIC	283
Keywords	Pharmaceutical Industry, Research And Development, Neurology, Innovation, MS, Rare Diseases, Multiple Sclerosis, Immunology, Patient Centric, Cystinuria, PKU, Formulation Technology, Tyrosinemia, HAE, AKU
Founded	2012
Employees	101-200
Socials

Cycle Pharmaceuticals Email Formats

Cycle Pharmaceuticals uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@cyclepharma.com), used 58% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@cyclepharma.com	58%
{first initial}.{last name}	j.doe@cyclepharma.com	42%

About Cycle Pharmaceuticals

We’re committed to supporting patients and their caregivers in every way we can. They are at the heart of everything we do. We focus on providing treatments and services for patients with neurological, rare metabolic, and rare immunological conditions, most of which are genetic conditions. We’re headquartered in Cambridge, UK and have staff working across the US, with an office in Detroit, MI.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Manager

Entry

Director

Employees by Department

Cycle Pharmaceuticals has 109 employees across 14 departments.

Departments

Number of employees

Funding Data

Explore Cycle Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-10-07	12	$25,000,000

Funding Insights

$25,000,000

Total funding amount

$25,000,000

Most recent funding amount

Number of funding rounds

Cycle Pharmaceuticals Tech Stack

Discover the technologies and tools that power Cycle Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

SiteGround

Hosting

Site Kit

Analytics

Vimeo

Video players

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

MailChimp

Google Analytics

Analytics

Frequently asked questions

Cycle Pharmaceuticals is located in Cambridge, England, GB.

You can reach Cycle Pharmaceuticals at +448009031793.

Cycle Pharmaceuticals generates an estimated annual revenue of $31,980,300. This revenue figure reflects the company's market position and business performance in its industry.

Cycle Pharmaceuticals has an estimated valuation of $102,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Cycle Pharmaceuticals was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

Cycle Pharmaceuticals has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Cycle Pharmaceuticals has raised a total of $25,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.